Clinical and dosimetric factors associated with a prolonged feeding tube requirement in patients treated with chemoradiotherapy (CRT) for head and neck cancers

Annals of Oncology

Volumn 21, Issue 1, 2009, Pages 145-151

  Gokhale, A S ^a   McLaughlin, B T ^a   Flickinger, J C ^a   Beriwal, S ^a   Heron, D E ^a   Ferris, R L ^a   Johnson, J ^a   Gibson, M K ^a   Argiris, A ^a   Smith, R P ^a  

^a UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

Author keywords

Chemoradiation; Dysphagia; Feeding tubes; Head and neck cancer; Quality of life

Indexed keywords

CARBOPLATIN; CETUXIMAB; CISPLATIN; DOCETAXEL; ERLOTINIB; FLUOROURACIL; PACLITAXEL;

ADENOID CYSTIC CARCINOMA; ADENOSQUAMOUS CARCINOMA; ADULT; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; COMPUTER ASSISTED RADIOTHERAPY; DOSIMETRY; FEEDING APPARATUS; FEMALE; HEAD AND NECK CANCER; HUMAN; LARYNX CANCER; LYMPHOEPITHELIOMA; MAJOR CLINICAL STUDY; MALE; NUTRITIONAL SUPPORT; PHARYNX CANCER; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; QUALITY OF LIFE; RADIATION DOSE; SPINDLE CELL CARCINOMA; SQUAMOUS CELL CARCINOMA; THYROID MEDULLARY CARCINOMA; TREATMENT DURATION; TREATMENT RESPONSE; TUMOR LOCALIZATION;

EID: 75649133685     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdp268     Document Type: Article

References (36)

1. Argiris A, Karamouzis MV, Raben D et al. Head and neck cancer. Lancet 2008; 371: 1695-1709.
2. The Department of Veterans Affairs Laryngeal Cancer Study Group. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. N Engl J Med 1991; 324: 1685-1690.
3. Lefebvre JL, Chevalier D, Luboinski B et al. Larynx preservation in pyriform sinus cancer: preliminary results of a European Organization for Research and Treatment of Cancer Phase III Trial. EORTC Head and Neck Cancer Cooperative Group. J Natl Cancer Inst 1996; 88: 890-899.
4. Al-Sarraf M, LeBlanc M, Giri PG et al. Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized intergroup study 0099. J Clin Oncol 1998; 16: 1310-1317.
5. Calais G, Alfonsi M, Bardet E et al. Randomized trial of radiation therapy versus concomitant chemotherapy and radiation therapy for advanced-stage oropharynx carcinoma. J Natl Cancer Inst 1999; 91: 2081-2086.
6. Forastiere AA, Goepfer H, Maor M et al. Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med 2003; 349: 2091-2098.
7. Cooper JS, Pajak TF, Forastiere AA et al. Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck. N Engl J Med 2004; 350(19): 1937-1944.
8. Bernier J, Domenge C, Ozsahin M et al. Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck Cancer. N Engl J Med 2004; 350(19): 1945-1952.
9. Low WK, Toh ST, Wee J et al. Sensorineural hearing loss after radiotherapy and chemoradiotherapy: a single, blinded, randomized study. J Clin Oncol 2006; 24: 1904-1909.
10. Eisbruch A, Haken RK, Kim HM et al. Dose, volume, and function relationships in parotid salivary glands following conformal and intensity-modulated irradiation of head and neck cancer. Int J Radiat Oncol Biol Phys 1999; 45(3): 577-587.
11. Pacholke HD, Amdur RJ, Morris CG et al. Late xerostomia after intensitymodulated radiation versus conventional radiotherapy. Am J Clin Oncol 2005; 28: 351-358.
12. Graff P, Lapeyre M, Desandes E et al. Impact of intensity-modulated radiotherapy on health-related quality of life for head and neck cancer patients: matched-pair comparison with conventional radiotherapy. Int J Radiat Oncol Biol Phys 2007; 67: 1309-1317.
13. Trotti A, Bellm LA, Epstein JB et al. Mucositis incidence, severity and associated outcomes in patients with head and neck cancer receiving radiotherapy with and without chemotherapy: a systematic literature review. Radiother Oncol 2003; 66: 253-262.
14. Rosenthal DI, Lewin JS, Eisbruch A. Prevention and treatment of dysphagia and aspiration after chemoradiation for head and neck Cancer. J Clin Oncol 2006; 24: 2636-2643.
15. Eisbruch AE, Schwartz M, Rasch C et al. Dysphagia and aspiration after chemoradiotherapy for head-and-neck cancer: which anatomic structures are affected and can they be spared by IMRT? Int J Radiat Oncol Biol Phys 2004; 60: 1425-1439.
16. Nguyen NP, Frank C, Moltz CC et al. Aspiration rate following chemoradiation for head and neck cancer: an underreported occurrence. Radiother Oncol 2006; 80: 302-306.
17. Nguyen NP, Moltz CC, Frank C et al. Dysphagia severity following chemoradiation and postoperative radiation for head and neck cancer. Eur J Radiol 2006; 59: 453-459.
18. Nguyen NP, Moltz CC, Frank C et al. Impact of swallowing therapy on aspiration rate following treatment for locally advanced head and neck cancer. Oral Oncol 2007; 43: 352-357.
19. Nguyen NP, Frank C, Moltz CC et al. Impact of dysphagia on quality of life after treatment of head and neck cancer. Int J Radiat Oncol Biol Phys 2005; 61: 772-778.
20. Walvekar R, Ferris RL. Complications of peg tubes. In: Eisele D, Smith RV (eds): Complications in Head and Neck Surgery, 2nd edition. St Louis, MS: Mosby 2008; 355-367.
21. Nguyen NP, Smith HJ, Sallah S. Evaluation and management of swallowing dysfunction following chemoradiation for head and neck cancers. Curr Opin Otolaryngol Head Neck Surg 2007; 15: 130-133.
22. Nguyen NP, Moltz CC, Frank C. Dysphagia following chemoradiation for locally advanced head and neck cancer. Ann Oncol 2004; 15: 383-388.
23. Staton J, Robbins KT, Newman L et al. Factors predicting poor outcome after chemoradiation for advanced laryngeal cancer. Otolaryngol Head Neck Surg 2002; 127: 43-47.
24. Shiley SG, Hargunani CA, Skoner JM et al. Swallowing function after chemoradiation for advanced stage oropharyngeal cancer. Otolaryngol Head Neck Surg 2006; 134: 455-459.
25. Ackerstaff AH, Tan IB, Rasch CR et al. Quality of life assessment after supradose selective intraarterial cisplatin and concomitant radiation for postoperative stage 4 head and neck cancer. Arch Otolaryngol Head Neck Surg 2002; 128: 1185-1190.
26. Samant S, Kumar P, Wan J et al. Concomitant radiation therapy and targeted cisplatin chemotherapy for the treatment of advanced pyriform sinus carcinoma: disease control and preservation or organ function. Head Neck 1999; 7: 595-601.
27. Feng FY, Kim HM, Lyden TH et al. Intensity-modulated radiotherapy of head and neck cancer aiming to reduce dysphagia: early dose-effect relationships for the swallowing structures. Int J Radiat Oncol Biol Phys 2007; 68(5): 1289-1298.
28. Levendag PC, Teguh DN, Voet P et al. Dysphagia disorders in patients with cancer of the oropharynx are significantly affected by the radiation therapy dose to the superior and middle constrictor muscle: a dose effect relationship. Radiother Oncol 2007; 85: 64-73.
29. Mangar S, Slevin N, Mais K et al. Evaluating predictive factors for determining enteral nutrition in patients receiving radical radiotherapy for head and neck cancer: a retrospective review. Radiother Oncol 2006; 78: 152-158.
30. Denham JW, Peters LJ, Johansen J et al. Do acute mucosal reactions lead to consequential late reactions in patients with head and neck cancer? Radiother Oncol 1999; 52: 157-164.
31. Lewin JS. Dysphagia after chemoradiation: prevention and treatment. Int J Radiat Oncol Biol Phys 2997; 69 (Suppl): S86-S87.
32. Murphy BA, Lewin JS, Ridner S et al. Mechanisms of weight loss in patients with head and neck cancer who were treated with chemotherapy. In: Perry MC (ed): American Society of Clinical Oncology 2006 Educational Book. Alexandria, VA: American Society of Clinical Oncology 2006; 340-344.
33. Al-Othman MOF, Amdur RJ, Morris CG et al. Does feeding tube placement predict for long-term swallowing disability after radiotherapy for head and neck cancer? Head Neck 2003; 25: 741-747.
34. Corry J, Poon W, McPhee N et al. Prospective study of percutaneous endoscopic gastrostomy tubes versus nasogastric tubes for enteral feeding in patients with head and neck cancer undergoing (chemo)radiation. Head Neck 2009.
35. Eisbruch A, Levendag PC, Feng FY et al. Can IMRT or brachytherapy reduce dysphagia associated with chemoradiotherapy of head and neck cancer? The Michigan and Rotterdam experiences. Int J Radiat Oncol Biol Phys 2007; 69 (Suppl): S40-S42.
36. Eisbruch A, Lyden T, Bradford CR et al. Objective assessment of swallowing dysfunction and aspiration after radiation concurrent with chemotherapy for head and neck cancer. Int J Radiat Oncol Biol Phys 2002; 53(1): 23-28.